How should healthcare organisations use blockchain when trust is fragmented across medical records and supply chains?

Healthcare teams should treat blockchain as a trust coordination layer, not a cure for bad data governance. It can help create shared records, improve provenance, and reduce reliance on a single controlling intermediary. The real work still includes access control, participant vetting, consent management, and data quality controls. Without those, distributed trust just automates bad inputs at scale.

Why This Matters for Security Teams

Healthcare organisations are using blockchain to coordinate trust where no single party can be assumed authoritative, especially across electronic health records, claims, labs, suppliers, and device vendors. That makes the question less about “should data live on-chain” and more about how to keep distributed participants honest. The OWASP Non-Human Identity Top 10 is relevant here because blockchain nodes, smart contract services, integration pipelines, and API clients all become machine identities that need governance.

The main risk is treating immutability as trust. Blockchain can preserve records, but it cannot verify whether the input was accurate, whether consent was valid, or whether a supplier was authorised at the time of submission. In healthcare, those failures are amplified by fragmented systems and overlapping obligations under privacy, safety, and operational continuity. NHI Management Group’s research on the 52 NHI Breaches Analysis shows how machine identities and third-party connections are often the weak link, not the ledger itself. In practice, many security teams encounter blockchain misuse only after bad data has already been shared across multiple organisations.

How It Works in Practice

For healthcare, blockchain works best as a provenance and coordination layer. It can timestamp events, record who asserted what, and create a shared audit trail across hospitals, pharmacies, distributors, insurers, and logistics providers. That is useful when trust is fragmented, but only if the surrounding identity and policy controls are mature. Current guidance suggests pairing blockchain with strong participant vetting, signed transactions, access scoping, and revocation processes rather than using the ledger as the primary security control.

Practitioners should think in terms of governance checkpoints:

• Use strong workload identity for every system that writes to or reads from the chain, not shared service accounts.
• Bind each transaction to an authenticated organisation, device, or workflow step so provenance is attributable.
• Store sensitive clinical or supplier data off-chain when possible, and keep only hashes, pointers, or commitments on-chain.
• Enforce consent, retention, and purpose limitations outside the ledger, because blockchain does not replace privacy policy.
• Continuously validate smart contracts, API integrations, and node operators, since a compromised participant can still submit trusted-looking garbage.

Healthcare teams should also align blockchain governance with broader machine-identity controls. The State of Secrets in AppSec research is a reminder that credential sprawl and delayed revocation remain common even in mature environments. That matters because ledger participation often depends on API keys, certificates, and tokens that outlive their business purpose. The NIST SP 800-53 Rev 5 Security and Privacy Controls supports the underlying discipline: identification, authentication, accountability, and least privilege. These controls tend to break down when healthcare networks integrate legacy EHRs, outsourced logistics, and multiple consortium operators because each party controls a different slice of the trust chain.

Common Variations and Edge Cases

Tighter blockchain governance often increases operational overhead, requiring organisations to balance stronger provenance against slower onboarding and more complex incident response. That tradeoff becomes sharper in healthcare because emergency workflows, supplier substitutions, and cross-border data exchange can create legitimate exceptions.

Best practice is evolving, but a few edge cases are clear. Private permissioned chains can reduce exposure, yet they do not remove the need for identity assurance among consortium members. Public chains may improve transparency, but they raise questions about patient confidentiality and regulatory fit. Smart contracts can automate reconciliation or recall workflows, but they also hard-code logic that may need rapid change during a safety event. The right model is usually hybrid: blockchain for shared verification, traditional controls for clinical correctness and privacy enforcement. For supply-chain use cases, the lesson from the Reviewdog GitHub Action supply chain attack is that trusted automation still depends on the security of every connected component, including build and deployment paths. Blockchain should strengthen inter-organisational trust, not replace source-of-truth systems or compensate for weak participant governance.

Related resources from NHI Mgmt Group

• How should organisations evaluate blockchain consensus choices when energy use and scalability both matter?
• What do organisations get wrong about decentralisation when evaluating blockchain for security use cases?
• How can organisations use blockchain to improve traceability in high-risk supply chains without overtrusting the ledger?
• How should organisations evaluate blockchain-based identity for enterprise access use cases?